麻疹特异性IgM和IgG抗体检测在疫苗免疫失败分类中的应用
研究基于天津市2013—2015年284例麻疹确诊病例,采用ELISA检测麻疹IgM和IgG抗体,并用ROC曲线分析IgM/IgG值区分原发性与继发性疫苗免疫失败的价值。结果显示IgM/IgG的AUC为0.952,最佳临界值0.06,灵敏度88.75%、特异度86.63%,并在2016年一起中学麻疹暴发(26例)中验证。
要点
- 麻疹IgM/IgG值区分PVF和SVF的AUC为0.952,优于单独IgM或IgG。
- 最佳临界值0.06,灵敏度88.75%、特异度86.63%。
- 2016年中学暴发急性期标本100%(26例)IgM/IgG<0.06。
核心结论
- ELISA检测麻疹IgM和IgG抗体后,采用IgM/IgG值判定原发性与继发性疫苗免疫失败具有良好的诊断价值。
研究设计与样本
- 利用麻疹监测信息系统收集天津市2013—2015年麻疹确诊病例284例,采集血清标本。
- 采用ELISA检测麻疹IgM和IgG抗体,以相对亲和力指数(RAI)判定亲和力。
- 采用ROC曲线分析IgM、IgG和IgM/IgG的判定价值,并用2016年天津市一起中学麻疹暴发(26例)进行验证。
主要发现
- 研究对象年龄0~58岁,采样间隔M(P25,P75)为2(1,4)天。
- 急性期标本麻疹IgM阳性率76.06%(216例),IgG阳性率88.38%(251例)。
- IgM、IgG和IgM/IgG的AUC分别为0.753、0.891和0.952,IgM/IgG区分PVF和SVF效果最佳。
- IgM/IgG>1时,96.30%(26例)为低亲和力(RAI<40%),仅1例为可疑(RAI 40%~60%)。
- IgM/IgG<0.01时,97.14%(102例)为高亲和力(RAI>60%),仅3例为可疑(RAI 40%~60%)。
关键数值与推荐
- IgM/IgG最佳临界值为0.06,灵敏度88.75%,特异度86.63%。
- 2016年中学麻疹暴发急性期标本中,100%(26例)IgM/IgG<0.06,84.62%(22例)IgM/IgG<0.01。
临床怎么用
- 对麻疹确诊病例,可结合急性期血清IgM/IgG值辅助区分原发性与继发性疫苗免疫失败。
- IgM/IgG<0.06提示可能为继发性免疫失败,>0.06提示可能为原发性免疫失败,需结合RAI等进一步判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To study the application of measles specific IgM and IgG antibody detection in classification of primary vaccination failure (PVF) and secondary vaccination failure (SVF). Methods: Measles surveillance information system was used to collect measles confirmed cases in Tianjin, 2013-2015, and their blood specimens were collected, totally 284 cases were enrolled. Measles IgM and IgG were detected with enzyme-linked immunosorbent assay (ELISA), and the relative avidity index (RAI) was used to express the result of measles avidity. Measles IgM, IgG and IgM/IgG was analyzed with receiver operating characteristic (ROC) curve, the area under the ROC curve (AUC) as evaluation indicators. In addition, compared with a measles outbreak (26 cases) of a middle school in Tianjin in 2016, for making further verification on the diagnostic value of vaccination failure with IgM, IgG and IgM/IgG. Results: The age of cases ranged was 0-58 years old, the interval median (P(25), P(75)) of serum collection after rash onset was 2 (1, 4) days. The positive rate of measles IgM and IgG in acute phase specimens were 76.06% (216 cases) and 88.38% (251 cases). According to the ROC curve analysis, the area under the ROC curve (AUC) of IgM, IgG and IgM/IgG were 0.753, 0.891 and 0.952, indicating that IgM/IgG was the best index to distinguish PVF and SVF. The best cut off value for IgM/IgG was 0.06, the sensibility and specificity were 88.75% and 86.63%. When IgM/IgG >1, 96.30% cases were low-avidity (RAI <40%), only 1 case was equivocal response (RAI: 40%-60%). 97.14% cases were high-avidity (RAI >60%) when IgM/IgG <0.01, only 3 cases were equivocal response (RAI 40%-60%). The threshold of IgM/IgG was used to verify the measles outbreak of a middle school in Tianjin, 2016. In the acute phase specimens, 100% (26 cases) of IgM/IgG were <0.06, 84.62% (22 cases) of IgM/IgG were <0.01. Conclusion: The detection of measles IgM and IgG with ELISA, and IgM/IgG is a valuable diagnostic tool to distinguish PVF and SVF. 目的: 探讨麻疹IgM和IgG抗体在判定原发性免疫失败(PVF)和继发性免疫失败(SVF)的应用。 方法: 以中国疾病预防控制信息系统中2013—2015年天津市上报的麻疹确诊病例为研究对象,获取其血清标本,共284例。采用ELISA检测麻疹IgM和IgG抗体,通过相对亲和力指数(RAI)判定亲和力检测结果;采用受试者工作特征(ROC)曲线分析麻疹IgM、IgG和IgM/IgG评价方法,利用曲线下面积(AUC)比较不同指标的判定价值。同时,对2016年天津市一起中学麻疹暴发(26例)进行分析,验证麻疹IgM、IgG和IgM/IgG评价方法在判定疫苗免疫失败的诊断价值。 结果: 研究对象年龄为0~58岁,采样间隔M(P(25),P(75))为2(1,4)d。麻疹IgM和IgG抗体阳性率分别为76.06%(216例)和88.38%(251例)。ROC曲线分析显示,麻疹IgM、IgG和IgM/IgG评价方法的AUC分别为0.753、0.891和0.952,采用麻疹IgM/IgG值判定PVF和SVF效果较好;麻疹IgM/IgG评价方法的最佳临界值为0.06,灵敏度88.75%,特异度86.63%。当麻疹IgM/IgG值>1时,96.30%(26例)的病例检测为低亲和力(RAI<40%),只有1例为可疑(RAI:40%~60%);当麻疹IgM/IgG值<0.01时,97.14%(102例)的病例为高亲和力(RAI>60%),只有3例为可疑(RAI:40%~60%)。以麻疹IgM/IgG值的临界值对2016年天津市中学麻疹暴发进行验证,急性期标本100%(26例)麻疹IgM/IgG值<0.06,84.62%(22例)麻疹IgM/IgG值<0.01。 结论: 利用ELISA方法检测麻疹IgM和IgG抗体后,采用麻疹IgM/IgG值判定PVF和SVF具有良好的诊断价值。.
引用
- Ding YX, Mao NY, Zhang Y, et al. [The application of measles specific IgM and IgG antibody detection in classification measles vaccine failure, Tianjin]. Zhonghua Yu Fang Yi Xue Za Zhi. 2019. PMID: 31091610. doi:10.3760/cma.j.issn.0253-9624.2019.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。